Concepedia

Anlin Hao

AH

Statistics

Publications

6

Citations

228

H-Index

6

Active since

2019

Affiliations

Anyang Tumor Hospital(Current)

Fudan University

Fujian Medical University

First Affiliated Hospital of Henan University of Science and Technology

Chinese Academy of Medical Sciences & Peking Union Medical College

Anlin Hao is an author at Anyang Tumor Hospital specializing in medicine, cancer research, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2019–2024

6

Publications

6

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · 144 citations · Full text

, , +16

NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway

Yaowen Zhang, Anping Zheng, Ruiping Xu et al. · Biochemical and Biophysical Research Communications · 2019 · 34 citations

, , +8

Chemotherapy plus camrelizumab versus chemotherapy alone as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (ESCORT-NEO): A multi-center, randomized phase III trial.

Yin Li, Jianjun Qin, Liyan Xue et al. · Journal of Clinical Oncology · 2024 · 15 citations

, , +16

Mirror siRNAs loading for dual delivery of doxorubicin and autophagy regulation siRNA for multidrug reversing chemotherapy

Bo Yang, Anlin Hao, Lin Chen · Biomedicine & Pharmacotherapy · 2020 · 13 citations · Full text

Diagnosis of Esophageal Squamous Cell Carcinoma by High‐Performance Serum Metabolic Fingerprints: A Retrospective Study

Yida Huang, Haijun Yang, Junkuo Li et al. · Small Methods · 2023 · 12 citations · Full text

Rows per page

1–5 of 6